Search This Blog

Tuesday, August 6, 2019

Antares Pharma EPS beats by $0.03, beats on revenue

Antares Pharma (NASDAQ:ATRS): Q2 GAAP EPS of -$0.01 beats by $0.03.
Revenue of $28.43M (+100.8% Y/Y) beats by $6.24M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)